Application of a 3-item adherence metric to monitor antiretroviral medication adherence in a resource-limited setting

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 4, 2010, Pages 528-

  Apisarnthanarak, Anucha ^a   Mundy, Linda M ^b  

^a THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^b Borow Consulting Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; CORRELATION ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SELF REPORT; THAILAND; TREATMENT OUTCOME;

EID: 78649335964     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181eec0c4     Document Type: Letter

References (5)

1. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14: 357-366.
2. Garcia de Olalla P, Knobel H, Carmona A, et al. Impact of adherence and highly active antire-troviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;10: 105-110.
3. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after one year of follow-up. AIDS. 2002;16: 1050-1058.
4. Paterson, DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
5. Mannheimer SB, Mukherjee R, Hirschhorn LR, et al. The CASE adherence index: A novel method for measuring adherence to antiretro-viral therapy. AIDS Care. 2006;18:853-861.